恒瑞医药
600276 · CN
I'm organizing the report structure and will only include the metrics that have actual data, leaving out EV/EBITDA, dividend yield, market cap, and the 52-week range since those weren't provided.# 600276 Research Preview
| Metric | Reading |
|---|---|
| Price | CNY 53.91 |
| Daily move | +0.86% |
| Day range | 52.88 / 54.56 |
| Overall score | 51/100 (Hold) |
| Trend | Consolidation |
| RSI14 / RSI6 | 49.44 / 39.90 (neutral) |
| MACD (line/signal/hist) | 0.97 / 1.25 / -0.28 (bearish config) |
| Estimated support | CNY 52.13 (+3.31% below) |
| Estimated resistance | CNY 57.44 (+6.56% above) |
| 30-session range position | +64.25% (range 46.56 / 58.00) |
| Data confidence | Medium (technicals); Low (news/sentiment) |
| Indicator | Reading | State |
|---|---|---|
| MA (5/10/20/60) | 54.85 / 55.15 / 54.78 / 51.81 | Mixed alignment; price -1.60% vs MA20 |
| RSI (14/6) | 49.44 / 39.90 | Neutral momentum |
| MACD (line/signal/hist) | 0.97 / 1.25 / -0.28 | Bearish config, above zero, momentum fading |
| KDJ (K/D/J) | 33.33 / 44.12 / 11.75 | Soft / still repairing |
| Bollinger (U/M/L) | 57.44 / 54.78 / 52.13 | Mid-band zone (34% of band) |
| ATR14 (abs / %) | 2.41 / +4.52% | Moderate volatility |
| OBV (value / 20-sess slope) | -383,427,103 / +37.01% | Accumulation improving |
| CCI20 | -56.64 | Inside neutral band |
Confirmed: The trend reads as consolidation across multiple inputs. RSI14 (49.44) and CCI20 (-56.64) both sit in neutral territory, and price is mid Bollinger band (34% of band width), so range-bound behavior is well corroborated. OBV's +37.01% 20-session slope points to improving accumulation even though the absolute OBV level is negative.
Conflicted: The MA structure is described as bullish alignment, yet the supplied values show MA10 (55.15) above MA5 (54.85), and price trades below MA20 (-1.60%). MACD is above the zero axis but in a death-cross posture with a negative histogram (-0.28), so trend-following and momentum signals disagree. KDJ is soft (J at 11.75) while OBV is improving, another short-term vs flow divergence.
Missing: No custom indicators were supplied beyond the standard panel, so none are folded in here. Intraday and multi-timeframe context are not provided.
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 45.3 | AkShare THS financial abstract | Medium |
| PB | 5.62 | AkShare THS financial abstract | Medium |
| PEG proxy | 2.52 | StockKit scenario model (not consensus) | Medium |
| Fair-value range | Bear CNY 23.86 / Base CNY 32.81 / Bull CNY 41.22 | StockKit DCF scenario model (not consensus) | Medium |
| Base fair-value gap | -39.1% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +10.00% / Base +18.00% / Bull +24.00% | StockKit scenario model | Medium |
| Revenue | CNY 31.63B | AkShare THS financial abstract | Medium |
| Net income | CNY 7.71B | AkShare THS financial abstract | Medium |
| EPS | 1.19 | AkShare THS financial abstract | Medium |
| Book value per share | 9.59 | AkShare THS financial abstract | Medium |
| Gross margin | +86.60% | AkShare THS financial abstract | Medium |
| Net margin | +28.02% | AkShare THS financial abstract | Medium |
The StockKit DCF scenario model places base fair value at CNY 32.81, a -39.1% gap versus the current CNY 53.91. These rows are internally computed forecasts built from public financial history, not analyst consensus targets, and should be read as one model's output rather than a price objective. Reported profitability is strong (gross margin +86.60%, net margin +28.02% on CNY 31.63B revenue), while the PEG proxy of 2.52 and PE of 45.3 indicate the market is pricing well above the model's growth-adjusted level. Income data uses the 2025-12-31 AkShare report period. EV/EBITDA, dividend yield, market cap, and 52-week range were not supplied and are omitted.
| Item | Status | Why it matters |
|---|---|---|
| Configured news source | No current news items available | No confirmed headline catalysts to weigh; near-term moves are more likely technical/flow-driven than event-driven |
Confirmed news: none in the supplied dataset. Missing data: the entire catalyst timeline. With no headlines available, this section carries low confidence, and no earnings dates, filings, or corporate actions are asserted here.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | No headlines | No source distribution available | Low |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No provider sentiment series was returned for this symbol. Because social feeds are not connected, no Reddit, X, StockTwits, or local-forum readings are inferred. This section is low confidence by construction.
| Scenario | Trigger conditions | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base (consolidation) | Price holds the 52.13-57.44 band; RSI14 stays near 49; volume remains below the 20-session average (currently -40.82%) | Continued mid-band drift, OBV slope staying positive (+37.01%) while KDJ repairs | A decisive close outside either watch level on expanding volume |
| Upside | Reclaim and hold above MA20 (54.78) then press resistance at 57.44; MACD histogram turns up from -0.28 | MACD line crossing back above signal (1.25), RSI6 recovering from 39.90, volume expanding on up-days | Rejection at 57.44 or failure to hold MA20 |
| Downside | Break below estimated support 52.13 (Bollinger lower); price stays under MA20 | KDJ staying soft (J 11.75), MACD death cross persisting, move toward lower 30-session range (46.56) | Reclaim of 52.13 and MA20 with OBV accumulation intact |
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Momentum rollover | MACD bearish config (0.97 < 1.25, hist -0.28); price -1.60% vs MA20 | Histogram widening negative; loss of MA20 | Watch daily MACD and MA20 |
| Support break | Support 52.13 only +3.31% below spot; KDJ soft (J 11.75) | Close below 52.13 | Track Bollinger lower band and range low 46.56 |
| Valuation gap | Base fair value CNY 32.81 vs price 53.91 (-39.1%); PE 45.3, PEG 2.52 | Growth disappointment vs +18% base forecast | Watch forward growth data as it appears |
| Thin catalyst/sentiment visibility | No news items; social not connected | New headlines emerging unpriced | Recheck news and sentiment feeds regularly |
| Volatility | ATR14 +4.52% of price | Range expansion beyond ATR | Size expectations to ATR; watch daily range vs 2.41 |
MA5>MA20金叉
MACD死叉，MACD在零轴上方，动能减弱
RSI14=49中性
在通道中部
缩量回调，可能企稳
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.